They're highly sensitive to the presence of the target DNA or RNA sequence in the sample well. But they can't easily tell if the target sequence they amplified came from the patient's sample or from other potential sources of contamination in the lab (the test, after all, makes billions of copies of the target DNA sequence), whether from other positive tests or from positive controls.